Both medications may be considered for individuals with obesity or who are overweight with at least one weight-related condition, such as high blood pressure, high cholesterol, or Type 2 diabetes
Wegovy is a clinically proven weight loss treatment that works in a similar way to Mounjaro, helping patients achieve up to a 14.9% reduction in body weight
Consequently, it is expected that the rate of diffusion within the tissue postinjection, as well as the transit across the capillary wall, will be reduced due to the increased molecular size of the albumin-peptide complex
Horne et al
When comparing oral semaglutide with injectable versions , the data is encouraging
In one screengrab, two women talk about Wegovy, and a large headline says lose weight and keep it off